CAS 328-90-5
:2-Hydroxy-4-(trifluormethyl)benzoesäure
- 2,4-Cresotic acid, α,α,α-trifluoro-
- 2-Hydroxy-4-(Trifluoromethyl)Benzoic Acid
- 2-Hydroxy-4-Trifluoromethylbenzoic Acid
- 4-(Trifluoromethy)Salicylic Acid
- 4-(Trifluoromethyl)-2-Hydroxybenzoic Acid
- 4-Trifluoromethyl Salicylic Acid
- 4-Trifluoromethylsalicylic Acid
- 4-Trifluoromethylsalicylicacid
- Benzoic Acid, 2-Hydroxy-4-(Trifluoromethyl)-
- P-Trifluoromethylsalicylicacid
- Rarechem Al Be 1424
- Trifluoromethylsalicylicacid
- p-(Trifluoromethyl)salicylic acid
- Weitere Synonyme anzeigen
4-(Trifluoromethyl)salicylic Acid
CAS:Formel:C8H5F3O3Reinheit:>98.0%(GC)(T)Farbe und Form:White to Almost white powder to crystalMolekulargewicht:206.124-Trifluoromethylsalicylic acid
CAS:Formel:C8H5F3O3Reinheit:97%Farbe und Form:SolidMolekulargewicht:206.1187Triflusal EP Impurity B
CAS:Kontrolliertes ProduktFormel:C8H5F3O3Farbe und Form:NeatMolekulargewicht:206.122-Hydroxy-4-(trifluoromethyl)benzoic acid
CAS:2-Hydroxy-4-(trifluoromethyl)benzoic acidFormel:C8H5F3O3Reinheit:98%Farbe und Form: white powderMolekulargewicht:206.12g/molTriflusal EP Impurity B-d3 (Desacetyl Triflusalic Acid-d3)
CAS:Formel:C8H2F3O3D3Molekulargewicht:209.14Desacetyl Triflusal
CAS:Applications The active metabolite of Triflusal; inhibits cardiac hypertrophy in vitro and in vivo by blocking the NF-κB signaling pathway.
References Bayon, Y., et al.: Br. J. Pharmacol., 126, 1359 (1999), Cabrero, A., et al.: Diabetes, 50, 1883 (2001), Cabrero, A., et al.: J. Biol. Chem., 277, 10100 (2002), Culebras, A., et al.: Neurology, 62, 1073 (2004),Formel:C8H5F3O3Farbe und Form:NeatMolekulargewicht:206.124-(Trifluoromethyl)salicylic acid
CAS:Formel:C8H5F3O3Reinheit:97%Farbe und Form:SolidMolekulargewicht:206.12Desacetyl triflusal
CAS:Triflusal is a drug that inhibits the production of colony-stimulating factor and energy metabolism. It has been shown to have beneficial effects on the liver in vivo. Triflusal also has a chemoattractant protein activity that may be useful for tumor therapy. The pharmacological treatment of triflusal is associated with an increased risk of cancer in humans, which can be attributed to its irreversible inhibition of cyclin D2. Triflusal may have therapeutic potential for treating pain and inflammation, but its use should be limited to patients at low risk for cancer.
Formel:C8H5F3O3Reinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:206.12 g/molRef: 3D-FD21130
Ausgelaufenes produkt








